Publications
5600 Results
- Journal / Conference
- Supportive Care in Cancer 2017 Apr;25(4):1191-1199; Dec 7 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID27928641
- PMC
- PMC5323355
- Study Number(s)
- S0702
Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702
- Journal / Conference
- Clinical Lung Cancer Jan;18(1):5-12; 2016 Jun 27 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Lung
- PMID
- PMID27473736
- PMC
- PMC5361177
- Study Number(s)
- S1400, S1403
Overview of thoracic oncology trials in cooperative groups around the globe
- Journal / Conference
- Clinical Genitourinary Cancer Dec;15(6):635-641; 2017 May 10 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Genitourinary
- PMID
- PMID28579151
- PMC
- PMC5734863
- Study Number(s)
- S0421
Validation of the association of RECIST changes with survival in men with metastatic castration resistant prostate cancer treated on SWOG study S0421
- Journal / Conference
- Journal of Clinical Oncology 35, 2017 (suppl 4S; abstract 520); ASCO GI Cancers Symposium (Jan 19-21, 2017, San Francisco, CA), poster, abst.#520
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1406
Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG1406)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl 4S; abstract TPS508); ASCO GI Cancers Symposium (January 19-21, 2017, San Francisco, CA), poster, abst. #TPS508
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
SWOG S1505: a randomized phase II study of peri-operative mFOLFIRINOX vs. gmcitabine/nab-paclitaxel as therapy for resectable pancreatic adenocarcinoma
- Journal / Conference
- Journal of Clinical Oncology 35, 2017 (suppl 4S; abstract 659); ASCO GI Cancers Symposium (Jan 19-21, 2017, San Francisco, CA), poster, abst.#659
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Associations of physical activity with survival and progression in metastatic colorectal cancer: results from CALGB 80405 (Alliance)
- Journal / Conference
- Mod Pathol 2017;30(S2):181A; USCAP 2017 Meeting (March 4-10, 2017, San Antonio, TX), poster
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Association of micropapillary architecture and high tumor budding with prognosis in patients with stage III colon cancer from a FOLFOX-based adjuvant chemotherapy Trial: NCCTG N0147 (Alliance)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl 4S; abstract 369); ASCO GI Cancers Symposium (Jan 19-21, 2017, San Francisco, CA), poster, abst.#369
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- R9704
Impact of diabetes and insulin use on prognosis in patients resected pancreatic cancer
- Journal / Conference
- Journal of Clinical Oncology 35, 2017(suppl 6S; abstract 2); ASCO GU Cancers Symposium (February16-18, 2017, Orlando, FL), oral
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9921
Adjuvant Androgen Deprivation (ADT) Versus Mitoxantrone Plus Prednisone (MP) Plus ADT in High Risk Prostate Cancer (PCa)Patients Following Radical Prostatectomy: A Phase III Intergroup Trial (SWOG S9921) NCT00004124
- Journal / Conference
- Journal of Clinical Oncology 35, 2017 (suppl 6S; abstract 181); ASCO GU Cancers Symposium (February16-18, 2017, Orlando, FL), poster
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/E3805